128 related articles for article (PubMed ID: 9138184)
1. Severe hypokalemia after budesonide treatment for Crohn's disease.
Rosenbach Y; Zahavi I; Rachmal A; Dinari G
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):352-5. PubMed ID: 9138184
[No Abstract] [Full Text] [Related]
2. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
[TBL] [Abstract][Full Text] [Related]
3. Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Hepatogastroenterology; 1997; 44(14):445-51. PubMed ID: 9164517
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis due to severe hypokaliemia in a Crohn's disease patient after budesonide treatment.
Mangone M; Spagnolo A; Capurso G; Marignani M; Panzuto F; Angeletti S; Ruggeri M; Menè P; Delle Fave G
Dig Liver Dis; 2007 Aug; 39(8):776-9. PubMed ID: 17049941
[TBL] [Abstract][Full Text] [Related]
5. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
Gastroenterology; 1996 Jan; 110(1):45-51. PubMed ID: 8536887
[TBL] [Abstract][Full Text] [Related]
6. Budesonide or prednisolone in active Crohn's disease.
Baert F; Rutgeerts P
Ann Med; 1995 Dec; 27(6):631. PubMed ID: 8652141
[No Abstract] [Full Text] [Related]
7. Budesonide in the management of patients with Crohn's disease.
Thomson AB; Sadowski D; Jenkins R; Wild G
Can J Gastroenterol; 1997 Apr; 11(3):255-60. PubMed ID: 9167034
[TBL] [Abstract][Full Text] [Related]
8. Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group.
Caesar I; Gross V; Roth M; Andus T; Schmidt C; Raedsch R; Weber A; Gierend M; Ewe K; Schölmerich J
Z Gastroenterol; 1995 May; 33(5):247-50. PubMed ID: 7610691
[TBL] [Abstract][Full Text] [Related]
9. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
[TBL] [Abstract][Full Text] [Related]
10. Oral budesonide in active Crohn's disease.
Löfberg R; Danielsson A; Salde L
Aliment Pharmacol Ther; 1993 Dec; 7(6):611-6. PubMed ID: 8161666
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release budesonide in Crohn's disease.
Drug Ther Bull; 1997 Apr; 35(4):30-1. PubMed ID: 9282408
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease.
Karamanolis G; Tzathas C; Triantafyllou K; Tsiamoulos Z; Ladas S
Inflamm Bowel Dis; 2006 Oct; 12(10):1010-1. PubMed ID: 17012977
[No Abstract] [Full Text] [Related]
13. [Budesonide in acute attacks of Crohn disease of medium intensity].
Marteau P
Gastroenterol Clin Biol; 1995 Apr; 19(4):459-60. PubMed ID: 7672543
[No Abstract] [Full Text] [Related]
14. Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group.
Greenberg GR; Feagan BG; Martin F; Sutherland LR; Thomson AB; Williams CN; Nilsson LG; Persson T
N Engl J Med; 1994 Sep; 331(13):836-41. PubMed ID: 8078529
[TBL] [Abstract][Full Text] [Related]
15. Severe hypokaliemia and metabolic alkalosis in a Crohn's disease patient after budesonide treatment: evidence for intestinal secretion of potassium.
Elriz K; Savoye G; Tamion F; Déchelotte P; Lerebours E
Dig Liver Dis; 2008 Feb; 40(2):149-50. PubMed ID: 18082475
[No Abstract] [Full Text] [Related]
16. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Crohn's disease with budesonide: this rose still has thorns!
Valentine JF
Am J Gastroenterol; 2002 Apr; 97(4):785-6. PubMed ID: 12003409
[No Abstract] [Full Text] [Related]
18. Allergic contact dermatitis from budesonide.
Veraldi S; Fallahdar D; Riboldi A
Contact Dermatitis; 1993 Feb; 28(2):116. PubMed ID: 8458207
[No Abstract] [Full Text] [Related]
19. Treatment of active Crohn's disease with an oral slow-release budesonide formulation.
Roth M; Gross V; Schölmerich J; Ueberschaer B; Ewe K
Am J Gastroenterol; 1993 Jun; 88(6):968-9. PubMed ID: 8503403
[No Abstract] [Full Text] [Related]
20. Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
Gross V; Andus T; Caesar I; Bischoff SC; Lochs H; Tromm A; Schulz HJ; Bär U; Weber A; Gierend M; Ewe K; Schölmerich J
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):905-9. PubMed ID: 8889459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
